Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Liver Tumor RF Adoption Could Grow With Imaging – UCLA Radiologist Lu

This article was originally published in The Gray Sheet

Executive Summary

Radiofrequency ablation (RFA) of liver tumors appears to be an effective bridge-to-transplant therapy, according to David Lu, MD, University of California, Los Angeles

You may also be interested in...



Will RF Ablation Replace Standard Treatment For Non-Surgical Liver Cancer?

Radiofrequency ablation's efficacy as a first-line therapy for hepatocellular carcinoma patients is supported by results from a 206-patient study, investigators report in the March issue of Radiology

‘Highly Questionable’ GMP Compliance In Pakistan Prompts New Licensing System

Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.

UsernamePublicRestriction

Register

MT021306

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel